Journal for ImmunoTherapy of Cancer (Nov 2021)
790 DSP502 — A novel approach for targeting TIGIT and PD1 pathways for cancer immunotherapy
- Shirley Greenwald,
- Ayelet Chajut,
- Alexandra Aronin,
- Amnon Peled,
- Matthew Weber,
- Ami Tamir,
- Iris Pecker,
- Rinat Tabakman,
- Lucy Ganthous,
- Liat Tamir,
- Roy Kahn,
- Jasmine Avichzer,
- Elina Zorde-Khvalevsky,
- Michal Michal Elhalel Dranitzki,
- Adam Foley-Comer,
- Mark Tykocinski
Affiliations
- Shirley Greenwald
- Aff38 grid.418916.30000000405064804Compugen Ltd Holon Israel
- Ayelet Chajut
- Aff38 grid.418916.30000000405064804Compugen Ltd Holon Israel
- Alexandra Aronin
- 2Commissioner of Standardization Administration Israel
- Amnon Peled
- 3Hadassah Medical Center, Jerusalem, Israel
- Matthew Weber
- 2Thomas Jefferson University, Philadelphia, PA, United States
- Ami Tamir
- 1Kahr Medical Ltd., Jerusalem, Israel
- Iris Pecker
- 1Kahr Medical Ltd., Jerusalem, Israel
- Rinat Tabakman
- 1Kahr Medical Ltd., Jerusalem, Israel
- Lucy Ganthous
- 1Kahr Medical Ltd., Jerusalem, Israel
- Liat Tamir
- 1Kahr Medical Ltd., Jerusalem, Israel
- Roy Kahn
- 1Kahr Medical Ltd., Jerusalem, Israel
- Jasmine Avichzer
- 1Kahr Medical Ltd., Jerusalem, Israel
- Elina Zorde-Khvalevsky
- 3Hebrew University Hospital, Jerusalem, AZ, Israel
- Michal Michal Elhalel Dranitzki
- 4Hadassah Medical Center, Jerusalem, Israel
- Adam Foley-Comer
- 1Kahr Medical Ltd., Jerusalem, Israel
- Mark Tykocinski
- 2Thomas Jefferson University, Philadelphia, PA, United States
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.790
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
